125 related articles for article (PubMed ID: 7564387)
1. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.
Reinfuss M; Stelmach A; Mitus J; Rys J; Duda K
J Surg Oncol; 1995 Oct; 60(2):89-94. PubMed ID: 7564387
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
3. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
5. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for supraclavicular lymph node recurrence in N1 breast cancer patients.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(4):2509-14. PubMed ID: 23725165
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
8. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
11. Lymph node yield as a prognostic factor in cancer studies--due to undersampling of tumor-free lymph nodes at higher N stages?
Metze K
Ann Surg Oncol; 2009 Apr; 16(4):1080-2; author reply 1083. PubMed ID: 18787904
[No Abstract] [Full Text] [Related]
12. Prognosis of Medullary Carcinoma of the Breast: 10 years' Experience in a Single Institution.
Kouhen F; Benhmidou N; Afif M; Rais F; Khamou M; Khanoussi B; El Menaoui O; Elkacemi H; Elmajjaoui S; Kebdani T; Benjaafar N
Breast J; 2017 Jan; 23(1):112-114. PubMed ID: 27671230
[No Abstract] [Full Text] [Related]
13. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in medullary breast cancer].
Mitze M; Goepel E
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):635-41. PubMed ID: 2777051
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.
Rakha EA; Aleskandarany M; El-Sayed ME; Blamey RW; Elston CW; Ellis IO; Lee AH
Eur J Cancer; 2009 Jul; 45(10):1780-7. PubMed ID: 19286369
[TBL] [Abstract][Full Text] [Related]
16. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
Yu J; Li G; Li J; Wang Y
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
Du J; Zhang Y; Ming J; Liu J; Zhong L; Liang Q; Fan L; Jiang J
World J Surg Oncol; 2016 Jun; 14(1):164. PubMed ID: 27335011
[TBL] [Abstract][Full Text] [Related]
18. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
19. The lymph node ratio as prognostic factor in node-positive breast cancer.
Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G
Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006
[TBL] [Abstract][Full Text] [Related]
20. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes.
Wong SL; Chao C; Edwards MJ; Carlson DJ; Laidley A; Noyes RD; McGlothin T; Ley PB; Tuttle T; Schadt M; Pennington R; Legenza M; Morgan J; McMasters KM;
Am J Surg; 2002 Dec; 184(6):492-8; discussion 498. PubMed ID: 12488144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
